Category: BMYMJN

Mead Johnson Has Right Market Formula

JGrimes
Some positive stock-market news on the health front today: Trading began in the stock of infant-formula maker Mead Johnson after its $720 million partial initial public offering.
Though there hasn’t been a successful IPO in months, investors appeared optimistic about Mead Johnson. Tuesday night the company even increased the size of its offering to […]

Continued Read ...
Posted in Drugs, BMY MJN  

 
Google
Web ekstrapalma.com

RSS Health Care Blog News